Gut microbes may become a new therapy for depression and anxiety
- The Rise of Immunocell Therapy and the Era of “Farewell to Chemotherapy”
- Second Death Linked to Red Yeast Rice Supplement Reported in Japan
- Why Was Dementia Almost Nonexistent in Ancient Greece and Rome?
- Common Household Chemicals Pose Potential Threat to Brain Health
- Alarming Levels of Lead Detected in Chicago Tap Water
- Ribociclib Plus Endocrine Therapy Shows Promise in Early Breast Cancer
Gut microbes may become a new therapy for depression and anxiety
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- Japan: Over 10,000 Applications for Health Damage from COVID-19 Vaccines
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- ‘Elixir of Immortality’ Nicotinamide Riboside (NR) Virtually No Effect
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Gut microbes may become a new therapy for depression and anxiety.
The role of the microbiome in the gut and systemic health has been closely watched by scientists for many years, and now there is growing evidence that this collection of microbes in the human gut also influences a person’s health.
Neurological and emotional health, recently, in a research report titled “Modulating brain function with microbiota” published in the international journal Science, scientists from McMaster University and other institutions found through research that the gut microbiome may It is expected to help develop new treatments for human psychiatric disorders.
In the article, the researchers outline how scientists are unraveling the connections between the microbiome and the body’s brain, including with diseases such as depression and amyotrophic lateral sclerosis.
Dr. Foster first discovered mice The association between gut microbes and anxiety disorders, and through animal studies, researchers have revealed specific microbial communities and associated metabolites that increase anxiety-like behavior and brain function in the body, translating these findings to the clinical population may be expected to help develop novel therapies that improve disease symptoms and clinical outcomes.
In this study, researchers uncovered a link between the human body’s 39 trillion gut microbes and a predisposition to brain disease.
Researcher Foster pointed out that there is some heterogeneity in patients at risk for or diagnosed with depression, so we hope to use biological mechanisms to understand specific biomarkers that can help define different populations.
Such a comprehensive approach may be necessary if researchers can find therapeutic answers for patients suffering from mental illness.
In addition, researchers are studying unidirectional and bipolar depression to better understand the causes of depression, identify new treatments and improve current ones.
Image source: https://www.science.org/doi/10.1126/science.abo4220
Madhukar H. Trivedi, MD, said, “I am very pleased that we are working with Foster to investigate the biology of human mental illness and mental health through a multi-pronged approach.
Researchers have previously uncovered how inflammation affects depression by looking for relevant immune markers in obtained blood samples.
They also looked for corresponding immune markers in stool samples collected from participants in the Texas Longitudinal Study of Antidepressants.
If samples from the bodies of people with depression can produce specific microbes that are associated with the success of certain antidepressant drugs or therapies, this may lead to individualized treatment for patients.
Researcher Foster said that we currently have a large number of treatment options, but such decisions are mainly based on behavioral and self-report, and in some cases, imaging and EEG information; antidepressants usually only affect about 40% , and other treatment options include cognitive behavioral therapy, deep brain stimulation, and even exercise and diet.
By expanding on individual patients, can researchers improve the number of patients who respond to a particular therapy? This may still need to be confirmed by further research in the future.
Original source:
Jane A. Foster, Modulating brain function with microbiota, Science (2022). DOI: 10.1126/science.abo4220
Gut microbes may become a new therapy for depression and anxiety
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.